Wordt geladen...
Targeting MEK5 impairs non-homologous end-joining repair and sensitizes prostate cancer to DNA damaging agents
Radiotherapy is commonly used to treat a variety of solid human tumors, including localized prostate cancer. However, treatment failure often ensues due to tumor intrinsic or acquired radioresistance. Here we find that the MEK5/ERK5 signaling pathway is associated with resistance to genotoxic stress...
Bewaard in:
| Gepubliceerd in: | Oncogene |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7085449/ https://ncbi.nlm.nih.gov/pubmed/31980741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-1163-1 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|